ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,871.51
      -0.41%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      02/12/20218:24AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/10/20219:24AMBusiness WireAdamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/01/20212:07PMBusiness WireAdamas Announces FDA Approval for Second Indication for GOCOVRI® as an Adjunctive Treatment to levodopa/carbidopa in Parkins...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/01/20218:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/01/20218:01AMBusiness WireAdamas Announces Settlement of Patent Litigation with ZydusNASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/22/20215:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/13/20219:27AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/13/20219:15AMGlobeNewswire Inc.Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/07/20216:02PMGlobeNewswire Inc.Adamas to Present at Upcoming ICR ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/05/20219:15AMGlobeNewswire Inc.Adamas Completes Acquisition of OSMOLEX ER®NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/04/20214:15PMGlobeNewswire Inc.Adamas to Present at Upcoming H.C. Wainwright ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/11/20204:02PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/02/20207:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/02/20206:51AMGlobeNewswire Inc.Adamas Announces Agreement to Amend Royalty-Backed Loan Agreement with HealthCare Royalty PartnersNASDAQ:ADMSAdamas Pharmaceuticals Inc
      12/02/20206:50AMGlobeNewswire Inc.Adamas Announces Agreement to Settle Patent Litigation with OsmoticaNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20205:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20205:53PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/24/20204:03PMGlobeNewswire Inc.Adamas to Present at Upcoming Evercore ISI ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/23/20209:21AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/23/20209:15AMGlobeNewswire Inc.Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan ...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/18/20204:02PMGlobeNewswire Inc.Adamas to Present at Upcoming Piper Sandler ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/13/20204:05PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/05/20204:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/05/20204:03PMGlobeNewswire Inc.Adamas Reports Third Quarter 2020 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/05/20204:02PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/02/20204:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      11/02/20209:25AMGlobeNewswire Inc.Adamas announces settlement agreement of previously disclosed class action litigationNASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/26/20204:04PMGlobeNewswire Inc.Adamas to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 5, 2020NASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/09/20204:03PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      10/01/20209:15AMGlobeNewswire Inc.Adamas appoints new Chief Medical Officer, Adrian Quartel, MDNASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS